Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao(Wuhan University), Cezmi A. Akdiş(University of Zurich)
Cited by 1,448
Related Papers
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
|Allergy|2020|1.2k
Role of interleukin 10 in specific immunotherapy.
|Journal of Clinical Investigation|1998|968
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells
|Journal of Allergy and Clinical Immunology|2009|332
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
|Journal of Clinical Investigation|2019|300
MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes
|Journal of Allergy and Clinical Immunology|2014|196